Health Innovators: Sidekick Health’s Saemundur “Sam” OddssonAs pharmaphorum’s founder, Dr Paul Tunnah, continues his Health Innovators video series, he connects with the co-founder of Share XHealth Innovators: Sidekick Health’s Saemundur “Sam” Oddssonhttps://pharmaphorum.com/digital/health-innovators-sam-oddson-sidekick/
Treatment for all: the key steps to better representation in pharmaAs people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says Share XTreatment for all: the key steps to better representation in pharmahttps://pharmaphorum.com/r-d/diversity-representation-pharma-clinical-trials/
Early detection of cancers will require blood sweat and tearsAn NHS study of a new cancer blood test holds huge promise, but will not be without its Share XEarly detection of cancers will require blood sweat and tearshttps://pharmaphorum.com/r-d/galleri-test-nhs-early-detection-cancers/
Virtual engagement and collaborations: the pharmaphorum podcastAs the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ Share XVirtual engagement and collaborations: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/virtual-engagement-impetus-digital
The benefits of being a family-run pharma companyThe third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on Share XThe benefits of being a family-run pharma companyhttps://pharmaphorum.com/sales-marketing/chiesi-family-run-pharma-company-benefits/
Addressing the HIV epidemic in Eastern Europe and Central AsiaWorking in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. 2021 Share XAddressing the HIV epidemic in Eastern Europe and Central Asiahttps://pharmaphorum.com/patients/gilead-hiv-epidemic-eastern-europe-central-asia/
It’s time to do better for patients with rare neurological disordersGlobal Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to Share XIt’s time to do better for patients with rare neurological disordershttps://pharmaphorum.com/patients/global-genes-rare-neurological-disorder-research/
The post-COVID future of physician sample access and engagementBuilding modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says Share XThe post-COVID future of physician sample access and engagementhttps://pharmaphorum.com/sales-marketing/covid-physician-pharma-access-engagement/
Taking stock of NHS medicines optimisationGiven the rising cost of medicines as a share of the NHS budget in England, the establishment of Share XTaking stock of NHS medicines optimisationhttps://pharmaphorum.com/patients/nhs-confederation-medicines-optimisation-ics/
